
About Hercules Capital
Hercules Capital (NYSE:HTGC) is a specialized finance company focused on providing senior secured loans to high-growth, innovative venture-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. Operating across the United States, Hercules Capital aims to offer customized financing solutions to their clients, addressing their unique needs while striving to maximize investor returns and achieve sustainable growth. Their projects span a wide range of sectors, from software and biotechnology to energy efficiency technologies, reflecting the company's commitment to supporting emerging market leaders and fostering innovation. Hercules Capital's objectives include maintaining a diversified loan portfolio, minimizing risk, and expanding its client base by leveraging its industry expertise and extensive network.
Snapshot
Operations
Products and/or services of Hercules Capital
- Venture debt financing for innovative start-up companies in technology, life sciences, and sustainable and renewable technology sectors.
- Customized growth capital solutions for early-stage and established businesses.
- Equity co-investment opportunities in portfolio companies for value-addition and strategic support.
- Warrant coverage services, providing the potential for additional capital gains through equity participation.
- Senior secured loans offering stable, secured, and structured financing options for growth-focused businesses.
- Direct equity investments to support companies in key transitional moments or growth phases.
Hercules Capital executive team
- Mr. Scott BluesteinCEO & CIO
- Mr. Seth Hardy MeyerChief Financial Officer
- Mr. Christian FollmannChief Operating Officer
- Ms. Kiersten Zaza BotelhoChief Legal Officer & Chief Compliance Officer
- Mr. Steve KuoSenior MD & Group Head of Technology
- Mr. Michael W. HaraManaging Director of Investor Relations & Corporate Communications
- Ms. Kate KinlinVP of Human Resources
- Mr. Roy Y. LiuManaging Director
- Mr. R. Bryan JadotSenior MD & Group Head of Life Sciences
- Mr. Michael BowdenManaging Director of Portfolio Management